The 2-Minute Rule for phenobarbital usage
Upon initiation or discontinuation of guselkumab in patients that are getting concomitant CYP450 substrates, particularly These with a slender therapeutic index, consider monitoring for therapeutic effect.フェニトインやカルバマゼピン、バルプロ酸など他の抗てんかん薬と同様に葉酸の吸収や代謝に影響し、貧